Xcout Intel
Rejuvenate Bio Inc competitors & alternatives
The 12 closest competitors and alternatives to Rejuvenate Bio Inc among biotech companies — ranked by similarity to what Rejuvenate Bio Inc actually does, not by market-cap band.
Subscribe to see Rejuvenate Bio Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Rejuvenate Bio Inc
Rejuvenate Bio, Inc. is a biotechnology company founded in 2019 and headquartered in San Diego, United States, specializing in innovative gene therapy applications.
Rejuvenate Bio Inc at a glance
Rejuvenate Bio Inc is a biotech company headquartered in United States. It has raised at least $34M across the 2 funding rounds on record. Its most recent funding round raised $19.5M in June 2026. Xcout tracks 7 named people at Rejuvenate Bio Inc, including Daniel Oliver (CEO, Co-Founder).
Rejuvenate Bio Inc leadership
- Daniel OliverCEO, Co-Founder
- Deborah AscheimChief Medical Officer
- Noah DavidsohnCSO, Co-Founder
- George ChurchCo-Founder and SAB
- Daniel OliverExecutive Officer
- Noah DavidsohnExecutive Officer
1 more named person on record for Rejuvenate Bio Inc, with roles, board committees and tenure — see the full roster →
Rejuvenate Bio Inc funding rounds
At least $34M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $19.5M | — | |
| Series A | $14.6M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Rejuvenate Bio Inc competitors
Ranked by semantic similarity — how close each company is to Rejuvenate Bio Inc by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Kriya Therapeutics, Inc. is a fully integrated biopharmaceutical company with operational footprints in Redwood City, California, and Research Triangle Park, North Carolina. The company develops novel gene therapies to address diverse diseases.
Life Science
ReCode Therapeutics is a clinical-stage genetic medicines company headquartered in Menlo Park, California, and Durham, North Carolina. The company leverages proprietary delivery systems to power a new class of disease-modifying genetic therapies.
Biotechnology
Ray Therapeutics, Inc. is a privately held optogenetic gene therapy company headquartered in Berkeley, California. The company focuses on reimagining vision through innovative genetic treatments and novel therapeutic solutions.
Biotechnology
Verve Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, dedicated to pioneering single-course gene editing medicines for cardiovascular disease.
Biotechnology
Gemma Labs Inc. (GEMMABio) is a biotechnology company that develops gene therapies for rare diseases using next-generation AAV technology. The company focuses on programs targeting motor neuron disorders, skeletal conditions, and cardiomyopathies to serve the rare disease community.
Biotechnology
Restore Vision Inc. is a Japanese startup headquartered in Tokyo that aims to develop visual restoration gene therapies.
Biotechnology
Prevail Therapeutics Inc. is a biotechnology company headquartered in New York City, New York, focused on developing gene therapies for patients with neurodegenerative diseases.
Similar biotech company
Adverum Biotechnologies is a clinical-stage biotechnology research company headquartered in Redwood City, California. The company focuses on developing novel gene therapies designed to redefine ocular care and treat severe eye diseases.
Biotechnology
HAYA Therapeutics is a precision medicines company developing RNA-guided therapeutics to target regulatory genomic dark matter for serious diseases. The company maintains dual roots with headquarters in Lausanne, Switzerland and a U.S. location in San Diego, California. It operates as a privately held biotech innovator.
Biotechnology
BreezeBio is a biotechnology company headquartered in the South San Francisco area of California that develops precision genetic medicines.
Biotechnology
Carmine Therapeutics, Inc. is an EVX Ventures company headquartered in Cambridge, Massachusetts, focused on developing novel gene therapies.
Similar biotech company
Endsulin, Inc. is a biotechnology company developing a liver-directed gene therapy for Type 1 Diabetes. Its proprietary technology aims to re-engineer liver cells to restore the body's natural ability to produce and regulate insulin, eliminating the need for artificial insulin delivery methods.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Rejuvenate Bio Inc and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Rejuvenate Bio Incand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →